PROTAC Linker

m-PEG1-NHS ester is a polyethylene glycol (PEG)-based linker designed for use in the synthesis of PROTACs (Proteolysis Targeting Chimeras). This compound facilitates the conjugation of ligands to E3 ligase while enhancing solubility and bioavailability. It is an essential reagent for researchers developing targeted protein degradation strategies and studying cellular pathways through the modulation of specific protein levels.

TCO-PEG2-amine is a PEG-based linker designed for use in the synthesis of PROTACs (Proteolysis Targeting Chimeras). This compound facilitates the targeted degradation of specific proteins through the ubiquitin-proteasome system, making it a valuable tool for chemical biology research. Its flexibility and solubility contribute to improved efficacy in the development of innovative therapeutic strategies targeting various diseases.

BCN-exo-PEG3-NH2 is a PEG-based linker designed for PROTAC (PROteolysis-TArgeting Chimeras) synthesis. This compound features a BCN (bicyclononyne) group that facilitates strain-promoted alkyne-azide cycloaddition (SPAAC) with azide-containing molecules. Its unique properties make it suitable for applications in targeted protein degradation research, enabling precise modulation of protein levels within biological systems.

Biotin-PEG2-CH2CH2N3 is a PEG-based linker designed for PROTAC synthesis, targeting protein degradation pathways. This compound features an azide group that facilitates copper-catalyzed azide-alkyne cycloaddition (CuAAc) with alkyne-containing molecules. Additionally, it is compatible with strain-promoted alkyne-azide cycloaddition (SPAAC) reactions involving DBCO or BCN-tagged compounds, making it versatile for diverse chemical biology applications, including targeted protein degradation studies.

Boc-NH-PEG3 is a polyethylene glycol (PEG)-based linker designed for use in the synthesis of PROTACs (proteolysis-targeting chimeras). This compound facilitates the assembly of PROTACs by providing a flexible and hydrophilic spacer that connects the target ligand and E3 ligase components. Its primary application lies in advancing research in targeted protein degradation, enabling the selective modulation of protein levels within cells.

Biotin-PEG12-NHS ester is a polyethylene glycol (PEG)-based PROTAC linker designed for the synthesis of proteolysis-targeting chimeras (PROTACs). This compound facilitates the covalent attachment of proteins through biotinylation, enhancing the pharmacokinetic properties of PROTACs. Its unique structure allows for improved solubility and stability, making it a valuable tool in targeted protein degradation research and drug discovery applications.

2-(2-((6-Chlorohexyl)oxy)ethoxy)acetic acid serves as a PROTACT linker, facilitating the targeted protein degradation of SMARCA2 and SMARCA4. This compound enhances the specificity and efficacy of proteolysis-targeting chimeras (PROTACs) by promoting the interaction between ligands and E3 ubiquitin ligases. It is an essential tool for researchers investigating protein homeostasis and therapeutic strategies in various biological contexts.

Boc-NH-PEG12-NH2 is a polyethylene glycol (PEG)-based linker designed for use in the synthesis of proteolysis-targeting chimeras (PROTACs). This compound facilitates the conjugation of target protein ligands to E3 ligase recruiters, enhancing the effectiveness of PROTACs in promoting targeted protein degradation. It is a valuable tool for researchers investigating novel therapeutic strategies through the modulation of protein homeostasis.

2-(4-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperazin-1-yl)acetic acid serves as a versatile PROTAC linker, facilitating the assembly of proteolysis-targeting chimeras. This compound effectively engages with E3 ligases, promoting targeted protein degradation. Its application is pivotal in the design and synthesis of hybrid molecules for research in drug discovery and therapeutic development.

2-(Bromomethyl)-1,3-dioxolane is a chemical linker specifically designed for use in synthesizing PROTACs (proteolysis-targeting chimeras). This compound facilitates the construction of bifunctional molecules that can selectively induce the degradation of target proteins through the ubiquitin-proteasome system. Its utility in the development of targeted protein degradation strategies makes it valuable for research in drug discovery and therapeutic applications.

tert-Butyl 8-aminooctanoate is a versatile PROTAC linker designed to facilitate the synthesis of PROTAC molecules. Its structure enables optimal interaction with target proteins, enhancing the overall efficacy of targeted protein degradation assays. This reagent is essential for researchers focused on investigating novel therapeutic strategies involving proteolysis-targeting chimeras.

mPEG45-Epoxide is a polyethylene glycol (PEG) derivative featuring polyether units, designed for use as a linker in PROTAC (Proteolysis Targeting Chimera) synthesis. This compound facilitates the conjugation of ligands to E3 ubiquitin ligases, enabling targeted protein degradation. mPEG45-Epoxide is instrumental in the development of novel therapeutic agents and in studying protein regulation mechanisms within cellular environments.

4-Boc-aminomethyl-piperidine is a versatile PROTAC linker that facilitates the development of targeted protein degradation therapies. This compound is essential for synthesizing various PROTACs, enabling the selective degradation of specific proteins within cellular pathways. Its application in research helps to advance therapeutic strategies for diseases driven by protein misregulation.

trans-4-[[(1,1-Dimethylethoxy)carbonyl]amino]cyclohexaneacetic acid acts as a PROTAC linker, facilitating the development of proteolysis-targeting chimeras. This compound is instrumental in the synthesis of PROTACs, which harness the cell's ubiquitin-proteasome system for targeted protein degradation. Its unique structure enhances the activity and specificity of PROTACs in various research applications, making it a critical reagent for studies in targeted therapy and protein modulation.

(E)-tert-Butyldimethyl((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)but-3-en-1-yl)oxy)silane serves as a versatile PROTAC linker, facilitating the assembly of proteolysis-targeting chimeras (PROTACs). This compound enables the selective degradation of target proteins via the ubiquitin-proteasome system and is instrumental in drug discovery and development. Its unique structure allows for effective conjugation, enhancing cellular permeability and targeting specificity in therapeutic applications.

tert-Butyl (7-azaspiro[3.5]nonan-2-yl)carbamate is a versatile PROTAC linker designed to facilitate the synthesis of PROTAC molecules. This compound enhances the targeted degradation of specific proteins through the ubiquitin-proteasome system, promoting effective protein removal. Its unique structural features support the development of novel therapeutic agents for research in targeted protein degradation.

tert-Butyl N-{2-azaspiro[3.4]octan-6-yl}carbamate serves as a PROTAC linker, facilitating the development of proteolysis-targeting chimeras (PROTACs). This compound enables the selective degradation of target proteins, enhancing cellular studies in target validation and therapeutic development. Its structural properties make it suitable for a variety of research applications in chemical biology and drug discovery.

tert-Butyl 9-amino-3-azaspiro[5.5]undecane-3-carboxylate serves as a link for PROTAC (proteolysis-targeting chimera) synthesis, facilitating the creation of bifunctional molecules that can selectively target specific proteins for degradation. This compound is instrumental in the field of targeted protein degradation research, enabling the development of novel therapeutics that can modulate protein levels in a controlled manner.

tert-Butyl (3-(hydroxymethyl)bicyclo[1.1.1]pentan-1-yl)carbamate is a specialized PROTAC linker designed for the synthesis of proteolysis-targeting chimeras (PROTACs). This compound facilitates the formation of covalent bonds between target proteins and E3 ligases, thus enhancing the ubiquitin-proteasome degradation pathway. Its effectiveness in linking various pharmacophores makes it a valuable tool for researchers exploring targeted protein degradation and related therapeutic applications.

Di(N-succinimidyl)adipate is an alkyl chain-based PROTAC linker that facilitates the development of proteolysis-targeting chimeras (PROTACs). Its structure allows for effective conjugation with various target proteins and E3 ligases, enabling the selective degradation of specific intracellular proteins. This reagent is essential for researchers aiming to explore targeted protein degradation mechanisms and develop innovative therapeutic strategies.

3-Maleimidopropionic acid is a versatile linker designed for use in the synthesis of PROTACs (Proteolysis Targeting Chimeras). Its maleimide functional group allows for the selective formation of thioether bonds with cysteine residues, facilitating targeted protein degradation. This compound is instrumental in advancing research in cellular signaling pathways and drug discovery by enabling the development of innovative therapeutics.

Biotin-EDA is an alkyl chain-based linker specifically designed for use in the synthesis of PROTACs (proteolysis-targeting chimeras). This compound facilitates targeted protein degradation by connecting E3 ligases to the protein of interest. Its unique structure enhances the efficiency of PROTAC development, making it a valuable tool in drug discovery and development for therapeutic interventions. Biotin-EDA is particularly useful in studies involving targeted therapeutics and protein regulation mechanisms.

Mal-NH2 TFA is an alkyl chain-based PROTAC linker designed for the synthesis of PROTACs (proteolysis-targeting chimeras). This compound facilitates the development of bifunctional molecules that can selectively target and degrade specific proteins within the cell. Its application is crucial in various research areas, including drug discovery and the investigation of protein function and degradation pathways.

Biotin-bis-amido-SS-NHS is a versatile PROTAC linker designed for targeted protein degradation applications. This compound facilitates the synthesis of PROTACs by enabling efficient conjugation to target proteins, leveraging the biotin-streptavidin interaction for cellular applications. Its unique structure enhances stability and biocompatibility, making it suitable for diverse research purposes in drug discovery and cellular biology.

CH2COOH-PEG6-CH2COOH is a polyethylene glycol (PEG)-based linker designed for use in the synthesis of PROTACs (proteolysis targeting chimeras). This compound facilitates the conjugation of target proteins and E3 ligase, enhancing the degradation of specific proteins through the ubiquitin-proteasome pathway. Its application is significant in drug discovery research, particularly in the development of targeted protein degradation therapies.

Icosane-1,20-diol serves as a versatile PROTAC linker, facilitating the development of proteolysis-targeting chimeras (PROTACs) for targeted protein degradation. Its unique structure enhances the molecular design of PROTACs, optimizing their biological activity and efficacy. This reagent is essential for researchers aiming to explore targeted therapies and investigate protein regulation mechanisms in various biological contexts.

2-(Benzyloxy)ethanol is a PEG-based PROTAC linker utilized in the synthesis of proteolysis-targeting chimeras (PROTACs). This compound provides a flexible and functional scaffold, facilitating the efficient degradation of target proteins through the ubiquitin-proteasome system. Its application in chemical biology enables researchers to explore targeted protein degradation mechanisms and therapeutic strategies.

Diethyl nonanedioate, also known as diethyl azelate, serves as a versatile PROTAC linker essential for the synthesis of Proteolysis Targeting Chimeras (PROTACs). This compound facilitates the selective degradation of target proteins via the ubiquitin-proteasome system, enabling researchers to investigate protein function and modulation. Its application in PROTAC development aids in the advancement of targeted therapy strategies in various diseases, including cancer and neurodegenerative disorders.

3-tert-Butyl-4-methoxyphenol serves as a PROTAC linker, facilitating targeted protein degradation. This compound exhibits unique biological activity, including insecticidal effects, and has been shown to enhance the activities of glutathione S-transferase and epoxide hydrolase in liver and forestomach tissues of A/HeJ mice. Its ability to regulate carcinogen metabolism makes it a valuable tool for research applications in cellular signaling and toxicology studies.

Cis-ethyl (1R,2S)-2-cyanocyclopropane-1-carboxylate is a versatile PROTAC linker designed for the synthesis of proteolysis-targeting chimeras (PROTACs). This compound facilitates the selective degradation of target proteins through the ubiquitin-proteasome system. Its unique structural features allow for enhanced binding specificity and efficacy in targeted protein degradation research applications.

1,3-Dibromo-5,5-dimethylhydantoin serves as an efficient alkyl chain-based PROTAC linker, facilitating the development of proteolysis-targeting chimeras (PROTACs). Its unique structure enables selective degradation of target proteins, making it a valuable tool in chemical biology research. This compound is crucial for researchers focused on novel therapeutic strategies involving targeted protein degradation.

1,6-Diiodohexane is a bifunctional linker designed for use in PROTAC (Proteolysis Targeting Chimeras) synthesis. Its unique structure facilitates the conjugation of target proteins to E3 ligases, enhancing the recruitment and degradation of specific proteins within the cell. This compound is valuable for researchers investigating targeted protein degradation mechanisms and developing novel therapeutics in protein homeostasis studies.

trans-1,4-Cyclohexanediamine serves as a versatile PROTAC linker, facilitating the development of targeted protein degradation tools. Its unique structure enhances the efficiency of PROTACs by promoting the selective degradation of target proteins via the ubiquitin-proteasome pathway. This compound is essential for researchers investigating novel therapeutic strategies in cancer and other diseases through protein modulation.